MSK Cancer Center research advances include proton therapy for leptomeningeal metastasis and evaluating large language models for cancer pain summary.
Key Details
- 1Proton therapy controls leptomeningeal metastasis, with patients living over twice as long versus conventional radiation.
- 2Randomized phase 2 trial: proton craniospinal therapy offers stability >3x longer for LM compared to standard radiation.
- 3Study funded by PCORI explores LLM-based PainReporter model to summarize cancer patient pain experiences from narrative notes.
- 4Research on tumor genetics and location finds SMAD4 reactivation suppresses liver metastases but increases lung metastases.
- 5Regulatory T cells, via enkephalin, regulate pain/inflammation in skin neuronal circuits.
Why It Matters
Advances in radiotherapeutic options like proton therapy improve outcomes in difficult cancer metastasis scenarios. Testing LLMs for summarising patient pain could impact clinical workflow, interpretation, and the integration of AI into patient care.
Source
EurekAlert
Related News
•EurekAlert
AI-Based Imaging Biomarker for Chronic Stress Validated on Chest CT
A deep learning model has identified and validated the first imaging biomarker for chronic stress using adrenal gland measurements from routine chest CT scans.
•EurekAlert
Multi-Algorithm Machine Learning Model Enhances Exacerbation Risk Prediction in COPD
A multi-algorithm machine learning model significantly improves risk prediction of acute exacerbations in COPD patients using multidimensional clinical data.
•EurekAlert
AI Simplifies CT Reports, Boosting Cancer Patients' Understanding
AI-driven text simplification significantly improves cancer patients' comprehension of CT scan reports.